TELA Bio, Inc. (TELA): Total Liabilities
$75.11M
As of 2025-12-31
$75.60M
As of 2026-06-30
+11.9%
3-year compound annual growth
+14.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $75.11M | +29.2% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $58.11M | -1.8% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $59.17M | +10.5% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $53.55M | +26.2% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $42.45M | +13.4% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $37.43M | +1.3% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $36.96M | -9.7% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $40.94M | n/a | 2020-03-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| TELA Bio, Inc. (TELA) | 2025-12-31 | $75.11M | +29.2% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $26.88M | +9.4% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $51.36M | -7.2% |
| Iradimed Corp (IRMD) | 2025-12-31 | $14.16M | +23.0% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $12.41M | +58.3% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $73.04M | -2.6% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $75.17M | -2.4% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $98.81M | +9.4% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $86.53M | -0.1% |
Compare TELA, PDEX, SGHT, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗